Search

Abbott Laboratories

Gesloten

SectorGezondheidszorg

102.98 0.45

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

101.62

Max

103.17

Belangrijke statistieken

By Trading Economics

Inkomsten

-149M

928M

Verkoop

1.4B

13B

K/W

Sectorgemiddelde

33.363

56.432

EPS

1.31

Dividendrendement

2.43

Winstmarge

7.369

Werknemers

122,000

EBITDA

-465M

1.8B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+21.17% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

2.43%

2.27%

Volgende Winsten

14 okt 2026

Volgende dividenddatum

16 nov 2026

Volgende Ex Dividend datum

15 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

16B

180B

Vorige openingsprijs

102.53

Vorige sluitingsprijs

102.98

Nieuwssentiment

By Acuity

39%

61%

81 / 339 Rangschikking in Healthcare

Abbott Laboratories Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 sep 2026, 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

16 sep 2026, 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

15 sep 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

14 sep 2026, 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

12 sep 2026, 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

11 sep 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market trading, settling at a cumulative return of 1.60%. The U.S. budget deficit for August was $167 billion.

10 sep 2026, 19:16 UTC

News

Abbott Laboratories received FDA approval for its TactiFlex Duo catheter. Shares are lower today, continuing a trend of declining prices over the past week.

9 sep 2026, 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

8 sep 2026, 20:02 UTC

News

Abbott Laboratories shares are lower, reaching a four-week low of $106.72 amid weakness in the Health Care Equipment sector despite FDA approval for its ablation catheter.

4 sep 2026, 20:07 UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

3 sep 2026, 23:31 UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2 sep 2026, 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

1 sep 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

31 aug 2026, 23:32 UTC

Correlated Moves

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

28 aug 2026, 23:16 UTC

Correlated Moves

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

27 aug 2026, 22:51 UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

26 aug 2026, 23:21 UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.

25 aug 2026, 23:26 UTC

Abbott Laboratories shares declined after-market, with no specific news identified. Broader market sentiment was affected by falling crude oil prices amid eased geopolitical tensions.

24 aug 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

21 aug 2026, 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

20 aug 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

19 aug 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

18 aug 2026, 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

17 aug 2026, 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

14 aug 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 aug 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 aug 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 aug 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 aug 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 aug 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

Peer Vergelijking

Prijswijziging

Abbott Laboratories Prognose

Koersdoel

By TipRanks

21.17% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 124.333 USD  21.17%

Hoogste 135 USD

Laagste 112 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Abbott Laboratories - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Sentiment

By Acuity

81 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.